Nexstim Plc

Nexstim is a Finnish medical technology company focused on developing non-invasive brain stimulation technologies. The company is known for its pioneering work in transcranial magnetic stimulation (TMS) combined with 3D navigation systems. Nexstim's products are designed to provide precise and individualized stimulation of brain areas, aiding in the diagnosis and treatment of challenging brain disorders. The company's mission is to enhance patient outcomes through innovative diagnostic and therapeutic solutions.

40

1.27

1.10

— Nexstim Plc
%
Diagnostic Systems40% Includes NBS 5 for brain mapping before surgery
Therapeutic Systems45% Includes NBT® and NBS 6 for treating brain disorders
Research and Neuroscience15% Involves sales of research devices and licenses

Nexstim's customers primarily include hospitals, clinics, and research institutions that require advanced brain mapping...

  • Hospitals and Clinicsprimary

    Purchase diagnostic and therapeutic systems for patient care

  • Research Institutionssecondary

    Acquire devices for neuroscience research

  • Academic Partnershipsemerging

    Collaborate on expanding technology applications

Nexstim operates primarily in the European Union and the United States, with a growing presence in Asia...

  • Headquartered in Finland with a strong presence in the EU and US
  • Expanding market reach in Asia through strategic partnerships
  • Global distribution with installations in leading hospitals
  • Focus on increasing presence in emerging markets

Nexstim's strategic priorities include expanding its market presence in Asia and enhancing its product offerings...

01
Expand market presence in Asiamedium-term

To increase global footprint and revenue

02
Enhance NBS 6 systemshort-term

To increase product versatility and application

Nexstim faces several risks, including regulatory challenges in obtaining and maintaining approvals for its medical...

critical

Regulatory challenges

Obtaining and maintaining device approvals

Materiality
high
high

Competitive pressures

Presence of other medical technology firms

Materiality
high
Revenue recognition
Significant on reported revenue
Currency fluctuations
Moderate

: 11/08/2026